Changsha Shengman Biotechnology Co., Ltd – Trademark Portfolio

Entity Type: 99

Changsha Shengman Biotechnology Co., Ltd holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include NIAOBINNEY. The owner is based in Changsha,Hunan.

No.506 Qingyuan road, Tianxin Dist,

Room 401'402 or 5 Floor-312, DILI Bldg

Changsha,Hunan 410004 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Changsha Shengman Biotechnology Co., Ltd's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does Changsha Shengman Biotechnology Co., Ltd have?

Changsha Shengman Biotechnology Co., Ltd has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Changsha Shengman Biotechnology Co., Ltd file in?

Changsha Shengman Biotechnology Co., Ltd files trademarks across 1 Nice Classification class. The most active classes are Class 9 (Computers & Electronics). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are Changsha Shengman Biotechnology Co., Ltd's most well-known trademarks?

Changsha Shengman Biotechnology Co., Ltd's registered trademark portfolio includes well-known marks such as NIAOBINNEY. These are among 1 currently registered trademark in the portfolio.

What is Changsha Shengman Biotechnology Co., Ltd's trademark registration success rate?

Changsha Shengman Biotechnology Co., Ltd has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.